Integra LifeSciences Holdings Profit Margin 2011-2025 | IART

Current and historical gross margin, operating margin and net profit margin for Integra LifeSciences Holdings (IART) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Integra LifeSciences Holdings net profit margin as of September 30, 2025 is -30.15%.
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.045B $1.611B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $215.010B 25.55
Intuitive Surgical (ISRG) United States $194.409B 76.06
IDEXX Laboratories (IDXX) United States $56.231B 55.84
Edwards Lifesciences (EW) United States $48.211B 32.33
Alcon (ALC) Switzerland $38.868B 26.27
IQVIA Holdings (IQV) United States $37.851B 21.11
Mettler-Toledo (MTD) United States $28.469B 33.31
DexCom (DXCM) United States $26.115B 36.00
STERIS (STE) Ireland $24.712B 25.51
Waters (WAT) United States $22.941B 30.34
Hologic (HOLX) United States $16.718B 17.56
SONOVA HOLDING (SONVY) Switzerland $14.969B 0.00
Penumbra (PEN) United States $12.219B 85.96
Globus Medical (GMED) United States $11.604B 24.35
Masimo (MASI) United States $7.431B 23.81
Glaukos (GKOS) United States $6.254B 0.00
Sysmex ADR (SSMXY) Japan $5.835B 18.54
Teleflex (TFX) United States $5.607B 8.94
TransMedics (TMDX) United States $4.333B 51.33
LivaNova (LIVN) United Kingdom $3.427B 18.51
Veracyte (VCYT) United States $3.386B 38.59
Alphatec Holdings (ATEC) United States $2.965B 0.00
Integer Holdings (ITGR) United States $2.548B 11.96
Elekta AB (EKTAY) Sweden $2.183B 20.42
Artivion (AORT) United States $2.138B 98.09
PROCEPT BioRobotics (PRCT) United States $2.011B 0.00
Nihon Kohden (NHNKY) Japan $1.826B 15.94
UFP Technologies (UFPT) United States $1.692B 22.35
Tandem Diabetes Care (TNDM) United States $1.450B 0.00
AxoGen (AXGN) United States $1.402B 0.00
Beta Bionics (BBNX) United States $1.310B 0.00
IRadimed (IRMD) United States $1.224B 58.32
OPKO Health (OPK) United States $1.059B 0.00
Pulse Biosciences (PLSE) United States $0.965B 0.00
SiBone (SIBN) United States $0.807B 0.00
Pacific Biosciences Of California (PACB) United States $0.640B 0.00
Tactile Systems Technology (TCMD) United States $0.621B 36.13
ORTHOFIX MEDICAL INC (OFIX) United States $0.613B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.545B 10.88
AngioDynamics (ANGO) United States $0.541B 0.00
NeuroPace (NPCE) United States $0.539B 0.00
RxSight (RXST) United States $0.519B 0.00
OrthoPediatrics (KIDS) United States $0.441B 0.00
Mesa Laboratories (MLAB) United States $0.429B 11.86
Alpha Tau Medical (DRTS) Israel $0.428B 0.00
Sight Sciences (SGHT) United States $0.428B 0.00
Delcath Systems (DCTH) United States $0.366B 61.00
ClearPoint Neuro (CLPT) United States $0.361B 0.00
Semler Scientific (SMLR) United States $0.275B 2.05
Spectral Diagnostics (EDTXF) Canada $0.269B 0.00
CVRx (CVRX) United States $0.221B 0.00
908 Devices (MASS) United States $0.216B 0.00
Nano-X Imaging (NNOX) Israel $0.211B 0.00
Anteris Technologies Global (AVR) Australia $0.205B 0.00
Inogen (INGN) United States $0.192B 0.00
Treace Medical Concepts (TMCI) United States $0.178B 0.00
Microbot Medical (MBOT) United States $0.162B 0.00
Rapid Micro Biosystems (RPID) United States $0.161B 0.00
Lucid Diagnostics (LUCD) United States $0.160B 0.00
Solana (HSDT) United States $0.139B 0.00
LENSAR (LNSR) United States $0.137B 0.00
Accuray (ARAY) United States $0.120B 0.00
Zomedica (ZOMDF) United States $0.109B 0.00
EDAP TMS S.A (EDAP) France $0.108B 0.00
Atossa Genetics (ATOS) United States $0.107B 0.00
Neuronetics (STIM) United States $0.104B 0.00
Hyperfine (HYPR) United States $0.097B 0.00
InspireMD (NSPR) United States $0.083B 0.00
DarioHealth (DRIO) United States $0.080B 0.00
QT Imaging Holdings (QTIH) United States $0.073B 0.00
Sensus Healthcare (SRTS) United States $0.063B 0.00
Positron (POSC) United States $0.050B 0.00
Spectral AI (MDAI) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.037B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.023B 0.00
Vicarious Surgical (RBOT) United States $0.017B 0.00
Adagio Medical Holdings (ADGM) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.014B 0.00
Tenon Medical (TNON) United States $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Check-Cap (MBAI) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 11.35
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00